136 related articles for article (PubMed ID: 8750244)
1. Effects of pravastatin in heart transplant recipients: implications of Kobashigawa et al.
Gotto AM
Curr Opin Lipidol; 1995 Dec; 6(6):341-3. PubMed ID: 8750244
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro.
Katznelson S; Wang XM; Chia D; Ozawa M; Zhong HP; Hirata M; Terasaki PI; Kobashigawa JA
J Heart Lung Transplant; 1998 Apr; 17(4):335-40. PubMed ID: 9588577
[TBL] [Abstract][Full Text] [Related]
3. Effect of pravastatin on outcomes after cardiac transplantation.
Kobashigawa JA; Katznelson S; Laks H; Johnson JA; Yeatman L; Wang XM; Chia D; Terasaki PI; Sabad A; Cogert GA
N Engl J Med; 1995 Sep; 333(10):621-7. PubMed ID: 7637722
[TBL] [Abstract][Full Text] [Related]
4. Reassuring effect of pravastatin on natural killer cell activity in stable renal transplant patients.
Vaessen LM; van Miert PP; van Gelder T; Ijzermans JN; Weimar W
Transplantation; 2001 Apr; 71(8):1175-9. PubMed ID: 11374422
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of pravastatin vs simvastatin after cardiac transplantation.
Keogh A; Macdonald P; Kaan A; Aboyoun C; Spratt P; Mundy J
J Heart Lung Transplant; 2000 Jun; 19(6):529-37. PubMed ID: 10867332
[TBL] [Abstract][Full Text] [Related]
6. The effect of pravastatin on acute rejection after kidney transplantation--a pilot study.
Katznelson S; Wilkinson AH; Kobashigawa JA; Wang XM; Chia D; Ozawa M; Zhong HP; Hirata M; Cohen AH; Teraski PI
Transplantation; 1996 May; 61(10):1469-74. PubMed ID: 8633373
[TBL] [Abstract][Full Text] [Related]
7. Lipid and apolipoprotein ratios: association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin.
Rader DJ; Davidson MH; Caplan RJ; Pears JS
Am J Cardiol; 2003 Mar; 91(5A):20C-23C; discussion 23C-24C. PubMed ID: 12646340
[TBL] [Abstract][Full Text] [Related]
8. Overlap analysis of the West of Scotland coronary prevention study (WOSCOPS).
Lim PO; Yee KM
Circulation; 1999 Aug; 100(6):686. PubMed ID: 10441109
[No Abstract] [Full Text] [Related]
9. Hypercholesterolemia is common after pediatric heart transplantation: initial experience with pravastatin.
Seipelt IM; Crawford SE; Rodgers S; Backer C; Mavroudis C; Seipelt RG; Pahl E
J Heart Lung Transplant; 2004 Mar; 23(3):317-22. PubMed ID: 15019641
[TBL] [Abstract][Full Text] [Related]
10. Who should receive statin therapy among the elderly?
Desilvey DL
Am J Geriatr Cardiol; 2006; 15(2):122. PubMed ID: 16525228
[No Abstract] [Full Text] [Related]
11. Recent developments in coronary heart disease prevention: the Scandinavian and west of Scotland studies.
Elam MB; Cushman W; Applegate WB; Heimberg M
Tenn Med; 1997 May; 90(5):189-92. PubMed ID: 9130876
[No Abstract] [Full Text] [Related]
12. Importance of high-density lipoprotein cholesterol control during pravastatin treatment in hypercholesterolemic Japanese with type 2 diabetes mellitus: a post hoc analysis of MEGA study.
Nishimura R; Sone H; Nakagami T; Tajima N
Diabetes Res Clin Pract; 2013 May; 100(2):e31-3. PubMed ID: 23522341
[TBL] [Abstract][Full Text] [Related]
13. Low HDL-C predicts the onset of transplant vasculopathy in pediatric cardiac recipients on pravastatin therapy.
Hedman M; Pahlman R; Sundvall J; Ehnholm C; Syvänne M; Jokinen E; Jauhiainen M; Holmberg C; Antikainen M
Pediatr Transplant; 2007 Aug; 11(5):481-90. PubMed ID: 17631015
[TBL] [Abstract][Full Text] [Related]
14. Effects of fluvastatin and pravastatin on lipid profiles and thromboxane production in type IIa hypercholesterolemia.
Milani M; Cimminiello C; Merlo B; Lorena M; Arpaia G; Bonfardeci G
Am J Cardiol; 1995 Jul; 76(2):51A-53A. PubMed ID: 7604798
[TBL] [Abstract][Full Text] [Related]
15. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
[TBL] [Abstract][Full Text] [Related]
16. Comparative beneficial effects of simvastatin and pravastatin on cardiac allograft rejection and survival.
Mehra MR; Uber PA; Vivekananthan K; Solis S; Scott RL; Park MH; Milani RV; Lavie CJ
J Am Coll Cardiol; 2002 Nov; 40(9):1609-14. PubMed ID: 12427413
[TBL] [Abstract][Full Text] [Related]
17. Statins improve visual field alterations related to hypercholesterolemia.
Alcalá A; Jansen S; Téllez T; Gómez-Huelgas R; Pérez O; Egido J; Farkouh ME
Atherosclerosis; 2010 Apr; 209(2):510-4. PubMed ID: 19892351
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups.
Blasetto JW; Stein EA; Brown WV; Chitra R; Raza A
Am J Cardiol; 2003 Mar; 91(5A):3C-10C; discussion 10C. PubMed ID: 12646336
[TBL] [Abstract][Full Text] [Related]
19. Survival, graft atherosclerosis, and rejection incidence in heart transplant recipients treated with statins: 5-year follow-up.
Stojanovic I; Vrtovec B; Radovancevic B; Radovancevic R; Yazdanbakhsh AP; Thomas CD; Frazier OH
J Heart Lung Transplant; 2005 Sep; 24(9):1235-8. PubMed ID: 16143239
[TBL] [Abstract][Full Text] [Related]
20. Summaries for patients. Benefits of lowering cholesterol levels in older patients.
Ann Intern Med; 2001 May; 134(10):S-4. PubMed ID: 11357858
[No Abstract] [Full Text] [Related]
[Next] [New Search]
